FindTrial
Sign In

Delivering radiation therapy to chest lymphomas(cancer) in deep inspiration.

A dosimetric and clinical study of DIBH in Mediastinal Lymphomas: An exploratory observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/014847
Enrollment
100
Registered
2018-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Mediastinal Lymphomas

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Center
Lead Sponsor
Department of Science and Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Radical intent, completed planned chemotherapy, biopsy proven 2.Age- 15- 60 years 3.Hodgkinâ??s lymphoma & Diffuse large B cell Lymphoma planned for mediastinal RT 4.Patient able to understand and comply with the procedures and a signed consent

Exclusion criteria

Exclusion criteria: 1.Palliative intent. 2.COPD patients & young children who are non-compliant

Design outcomes

Primary

MeasureTime frame
Clinical , biochemical and functional morbiditiesTimepoint: Every 3 Months for one year and then every 6 months for 3 years and then yearly for till 14 years—

Secondary

MeasureTime frame
1.Dosimetric Endpoint: 2.Incidence of Pulmonary function test changes/ radiation induced pneumonitis. 3.Incidence of Thyroid Function abnormalities. 4.Incidence of Radiation induced Second cancer if any. Timepoint: Every 3 Months for one year and then every 6 months for 3 years and then yearly for till 14 years—

Countries

India

Contacts

Public ContactDr Raziuddin khwaja

TATA MEMORIAL CENTRE

godajayantsastri@gmail.com9930004414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026